REG - Susquehanna Ire. Ltd Shire plc Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Limited
RNS Number : 5859LSusquehanna Ireland Ltd27 December 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Susquehanna International Holdings LLC ("SIHLLC")
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
n/a
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical Company Limited
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
n/a
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
24/12/2018
25/12/2018
26/12/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES -Shire Plc
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary Stock ISIN: JP3463000004
ISIN: US8740602052
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,600
(2) Cash-settled derivatives:
0
(4,547,800)
-0.58%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:
1,600
(4,547,800)
-0.58%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
ORD
PURCHASE
10100
3639
ORD
PURCHASE
18300
3640
ORD
PURCHASE
5800
3640
ORD
PURCHASE
500
3643
ORD
PURCHASE
200
3644
ORD
PURCHASE
3400
3644
ORD
PURCHASE
200
3640
ORD
PURCHASE
400
3648
ORD
PURCHASE
2000
3651
ORD
PURCHASE
100
3650
ORD
PURCHASE
500
3652
ORD
PURCHASE
200
3658
ORD
PURCHASE
100
3660
ORD
PURCHASE
300
3660
ORD
PURCHASE
300
3664
ORD
PURCHASE
100
3672
ORD
PURCHASE
100
3675
ORD
PURCHASE
200
3676
ORD
PURCHASE
300
3676
ORD
PURCHASE
200
3676
ORD
PURCHASE
100
3677
ORD
PURCHASE
200
3677
ORD
PURCHASE
4600
3679
ORD
PURCHASE
1700
3680
ORD
PURCHASE
200
3680
ORD
PURCHASE
200
3681
ORD
PURCHASE
200
3686
ORD
PURCHASE
200
3693
ORD
PURCHASE
200
3696
ORD
PURCHASE
700
3667
ORD
PURCHASE
700
3667
ORD
PURCHASE
300
3667
ORD
PURCHASE
100
3668
ORD
PURCHASE
100
3665
ORD
PURCHASE
700
3660
ORD
PURCHASE
100
3651
ORD
PURCHASE
1000
3659
ORD
PURCHASE
4500
3660
ORD
PURCHASE
3200
3655
ORD
PURCHASE
1600
3655
ORD
PURCHASE
900
3656
ORD
PURCHASE
11100
3655
ORD
PURCHASE
200
3656
ORD
PURCHASE
600
3658
ORD
PURCHASE
2800
3659
ORD
PURCHASE
100
3660
ORD
PURCHASE
500
3660
ORD
PURCHASE
100
3660
ORD
PURCHASE
500
3660
ORD
PURCHASE
200
3660
ORD
PURCHASE
300
3660
ORD
PURCHASE
200
3660
ORD
PURCHASE
3300
3658
ORD
PURCHASE
2700
3659
ORD
PURCHASE
1800
3660
ORD
PURCHASE
300
3661
ORD
PURCHASE
100
3653
ORD
PURCHASE
6400
3654
ORD
PURCHASE
1100
3654
ORD
PURCHASE
1700
3654
ORD
PURCHASE
400
3654
ORD
PURCHASE
400
3655
ORD
PURCHASE
3400
3650
ORD
PURCHASE
100
3650
ORD
PURCHASE
1300
3651
ORD
PURCHASE
500
3651
ORD
PURCHASE
500
3652
ORD
PURCHASE
600
3653
ORD
PURCHASE
100
3654
ORD
PURCHASE
400
3654
ORD
PURCHASE
1400
3656
ORD
PURCHASE
100
3657
ORD
PURCHASE
100
3657
ORD
PURCHASE
2200
3657
ORD
PURCHASE
1000
3656
ORD
PURCHASE
400
3656
ORD
PURCHASE
400
3656
ORD
PURCHASE
100
3656
ORD
PURCHASE
800
3656
ORD
PURCHASE
1100
3656
ORD
PURCHASE
1000
3657
ORD
PURCHASE
100
3662
ORD
PURCHASE
500
3650
ORD
PURCHASE
100
3650
ORD
PURCHASE
300
3649
ORD
PURCHASE
1600
3651
ORD
PURCHASE
100
3651.5
ORD
PURCHASE
100
3651.5
ORD
PURCHASE
100
3630
ORD
PURCHASE
200
3630.5
ORD
PURCHASE
800
3620
ORD
PURCHASE
1300
3622
ORD
PURCHASE
1700
3622
ORD
PURCHASE
200
3629
ORD
PURCHASE
600
3629
ORD
PURCHASE
100
3702
ORD
PURCHASE
200
3701
ORD
PURCHASE
200
3704
ORD
PURCHASE
100
3705
ORD
PURCHASE
200
3706
ORD
PURCHASE
200
3707
ORD
PURCHASE
1800
3710
ORD
PURCHASE
100
3702
ORD
PURCHASE
300
3703
ORD
PURCHASE
200
3704
ORD
PURCHASE
100
3700
ORD
PURCHASE
500
3701
ORD
PURCHASE
300
3725
ORD
PURCHASE
100
3727
ORD
PURCHASE
1000
3721
ORD
PURCHASE
400
3722
ORD
PURCHASE
2100
3730
ORD
PURCHASE
100
3732
ORD
PURCHASE
1100
3731
ORD
PURCHASE
200
3732
ORD
PURCHASE
100
3733
ORD
PURCHASE
200
3733
ORD
PURCHASE
1800
3737
ORD
PURCHASE
300
3742
ORD
PURCHASE
200
3743
ORD
PURCHASE
100
3736.5
ORD
PURCHASE
1000
3725
ORD
PURCHASE
100
3727
ORD
PURCHASE
500
3727
ORD
PURCHASE
100
3725
ORD
PURCHASE
100
3725
ORD
PURCHASE
700
3724
ORD
PURCHASE
500
3725
ORD
PURCHASE
100
3727
ORD
PURCHASE
2100
3720
ORD
PURCHASE
100
3718
ORD
PURCHASE
3700
3705
ORD
PURCHASE
1000
3706
ORD
PURCHASE
9500
3710
ORD
PURCHASE
100
3696
ORD
PURCHASE
1000
3671
ORD
PURCHASE
800
3715
ORD
PURCHASE
100
3715
ORD
PURCHASE
700
3718
ORD
SALE
-100
3644
ORD
SALE
-300
3642
ORD
SALE
-200
3645
ORD
SALE
-900
3640
ORD
SALE
-200
3640
ORD
SALE
-300
3648
ORD
SALE
-100
3646
ORD
SALE
-100
3644
ORD
SALE
-15900
3640
ORD
SALE
-200
3638
ORD
SALE
-200
3640
ORD
SALE
-100
3641
ORD
SALE
-100
3642
ORD
SALE
-200
3641
ORD
SALE
-1200
3640
ORD
SALE
-100
3641
ORD
SALE
-200
3640
ORD
SALE
-100
3641
ORD
SALE
-100
3643
ORD
SALE
-100
3643
ORD
SALE
-200
3643
ORD
SALE
-300
3645
ORD
SALE
-100
3645
ORD
SALE
-200
3643
ORD
SALE
-100
3643
ORD
SALE
-200
3643
ORD
SALE
-100
3643
ORD
SALE
-300
3640
ORD
SALE
-200
3635
ORD
SALE
-300
3639
ORD
SALE
-600
3630
ORD
SALE
-100
3640
ORD
SALE
-300
3636
ORD
SALE
-200
3640
ORD
SALE
-100
3640
ORD
SALE
-100
3640
ORD
SALE
-100
3640
ORD
SALE
-100
3639
ORD
SALE
-100
3640
ORD
SALE
-100
3640
ORD
SALE
-200
3640
ORD
SALE
-100
3640
ORD
SALE
-200
3640
ORD
SALE
-100
3640
ORD
SALE
-2100
3678
ORD
SALE
-200
3677
ORD
SALE
-400
3676
ORD
SALE
-2600
3674
ORD
SALE
-400
3676
ORD
SALE
-1900
3675
ORD
SALE
-900
3675
ORD
SALE
-400
3691
ORD
SALE
-2300
3690
ORD
SALE
-100
3689
ORD
SALE
-700
3690
ORD
SALE
-700
3682
ORD
SALE
-800
3681
ORD
SALE
-3500
3680
ORD
SALE
-600
3680
ORD
SALE
-1100
3679
ORD
SALE
-1400
3678
ORD
SALE
-500
3677
ORD
SALE
-300
3676
ORD
SALE
-200
3673
ORD
SALE
-300
3672
ORD
SALE
-4100
3670
ORD
SALE
-600
3671
ORD
SALE
-700
3670
ORD
SALE
-600
3670
ORD
SALE
-2300
3669
ORD
SALE
-600
3667
ORD
SALE
-900
3666
ORD
SALE
-100
3661
ORD
SALE
-2700
3660
ORD
SALE
-100
3660
ORD
SALE
-100
3658
ORD
SALE
-100
3658
ORD
SALE
-100
3662
ORD
SALE
-700
3665
ORD
SALE
-300
3659
ORD
SALE
-300
3657
ORD
SALE
-200
3654
ORD
SALE
-1200
3650
ORD
SALE
-1200
3653
ORD
SALE
-100
3651
ORD
SALE
-3100
3650
ORD
SALE
-1300
3647
ORD
SALE
-1500
3652
ORD
SALE
-4700
3650
ORD
SALE
-4200
3650
ORD
SALE
-400
3649
ORD
SALE
-500
3659
ORD
SALE
-800
3660
ORD
SALE
-1300
3658
ORD
SALE
-3300
3657
ORD
SALE
-700
3658
ORD
SALE
-200
3656
ORD
SALE
-1000
3663
ORD
SALE
-100
3660
ORD
SALE
-500
3659
ORD
SALE
-800
3661
ORD
SALE
-700
3661
ORD
SALE
-500
3658
ORD
SALE
-300
3659
ORD
SALE
-500
3659
ORD
SALE
-300
3658
ORD
SALE
-2300
3657
ORD
SALE
-1900
3656
ORD
SALE
-2000
3654
ORD
SALE
-300
3653
ORD
SALE
-100
3653
ORD
SALE
-1100
3652
ORD
SALE
-2600
3650
ORD
SALE
-2100
3652
ORD
SALE
-100
3651
ORD
SALE
-1400
3650
ORD
SALE
-1600
3652
ORD
SALE
-1200
3653
ORD
SALE
-900
3651
ORD
SALE
-1700
3651
ORD
SALE
-1600
3649
ORD
SALE
-1000
3652
ORD
SALE
-2400
3651
ORD
SALE
-2100
3650
ORD
SALE
-200
3649
ORD
SALE
-400
3650
ORD
SALE
-1200
3649
ORD
SALE
-100
3649
ORD
SALE
-900
3648
ORD
SALE
-500
3649
ORD
SALE
-1400
3648
ORD
SALE
-800
3647
ORD
SALE
-200
3649
ORD
SALE
-600
3651
ORD
SALE
-1000
3650
ORD
SALE
-600
3648
ORD
SALE
-2100
3650
ORD
SALE
-300
3628
ORD
SALE
-1000
3640
ORD
SALE
-2900
3701
ORD
SALE
-100
3698
ORD
SALE
-100
3698
ORD
SALE
-500
3690
ORD
SALE
-100
3678
ORD
SALE
-900
3709
ORD
SALE
-900
3714
ORD
SALE
-300
3718
ORD
SALE
-500
3715
ORD
SALE
-100
3712
ORD
SALE
-200
3711
ORD
SALE
-100
3713
ORD
SALE
-1400
3725
ORD
SALE
-1400
3724
ORD
SALE
-400
3723
ORD
SALE
-1300
3720
ORD
SALE
-1200
3719
ORD
SALE
-500
3719
ORD
SALE
-500
3718
ORD
SALE
-100
3719
ORD
SALE
-500
3718
ORD
SALE
-1200
3717
ORD
SALE
-200
3716
ORD
SALE
-200
3717
ORD
SALE
-700
3714
ORD
SALE
-800
3713
ORD
SALE
-900
3712
ORD
SALE
-700
3710
ORD
SALE
-200
3711
ORD
SALE
-400
3708
ORD
SALE
-300
3707
ORD
SALE
-400
3706
ORD
SALE
-900
3705
ORD
SALE
-100
3708
ORD
SALE
-2200
3704
ORD
SALE
-700
3702
ORD
SALE
-1600
3700
ORD
SALE
-500
3699
ORD
SALE
-700
3698
ORD
SALE
-200
3698
ORD
SALE
-600
3698
ORD
SALE
-900
3696
ORD
SALE
-2000
3693
ORD
SALE
-200
3692
ORD
SALE
-1200
3693
ORD
SALE
-1700
3690
ORD
SALE
-1700
3690
ORD
SALE
-500
3686
ORD
SALE
-100
3685
ORD
SALE
-400
3681
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
NO
Date of disclosure:
27/12/2018
Contact name:
Diana Taraseviciute /Olive Fogarty
Telephone number*:
353-1-8028419/8059
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETPGGAUPUPRGPM
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement